Chinese Medical Journal (Sep 2021)

Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes

  • Jing-Yi Hu,
  • Hai-Lan Zou,
  • Yan-Hua Li,
  • Dong-Ying Nie,
  • Chen Chao,
  • Jin-Han Liu,
  • Jin Ding,
  • Zhi-Guang Zhou,
  • Yang Xiao,
  • Ning-Ning Wang

DOI
https://doi.org/10.1097/CM9.0000000000001574
Journal volume & issue
Vol. 134, no. 18
pp. 2243 – 2245

Abstract

Read online

No abstracts available.